Ladenburg Thalmann Downgrades Capricor Therapeutics (CAPR) to Neutral
Ladenburg Thalmann analyst Aydin Huseynov downgraded Capricor Therapeutics (NASDAQ ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
